1-8 of 8
Hailin Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Updated Comparison of Clinical Outcomes from 4-Year Follow-up of Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma

John G. Gribben, Paola Ghione, Maria Lia Palomba, Markqayne D Ray, Eve H Limbrick-Oldfield, Steve Kanters, Sabela Bobillo, Maria Teresa Ribiero, Caron A Jacobson, Sattva S. Neelapu, Herve Ghesquieres, Olga Nikolajeva, Jiali Yan, Hailin Wang, Anik R Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 4869.
https://doi.org/10.1182/blood-2023-186842
Published: 2023
Journal Articles

Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma

Baohui Wang, Xiao Huang, Jianming Sun, Yurong Qin, Hongyan Shang, Tingting Li, Guojin Wu, Min Chen, Hailin Wang, Peng Zhang, Duqing Jiang, Tongjun Liu, Mi Ye, Shengli Cai, Shoupeng Lai, Xiaoqiang Kang, Hong Ling
Journal: Blood
Blood (2023) 142 (Supplement 1): 4672.
https://doi.org/10.1182/blood-2023-181395
Published: 2023
Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Bronwen E. Shaw, PhD MRCP, FRCPath, Brent R. Logan, PhD, Stephen R. Spellman, Steven GE Marsh, BSc, PhD ARCS, James Robinson, BSc, MSc, Joseph Pidala, MD PhD, Carolyn Hurley, PhD, Juliet Barker, MBBS, Martin Maiers, PhD, Jason Dehn, MPH, Hailin Wang, MPH, Michael Haagenson, MS, David L Porter, MD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD MS, Michael R Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Stephanie J Lee, MD MPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 848.
https://doi.org/10.1182/blood.V130.Suppl_1.848.848
Published: 2017
Journal Articles

Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers

Chezi Ganzel, Vikram Mathews, DM, Kamran Alimoghaddam, MD, Ardeshir Ghavamzadeh, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Hailin Wang, Daniel Weisdorf, MD, Dan Douer, MD, Jacob M. Rowe, MD, Arnon Nagler, MD MSc, Mohamad Mohty, Martin S. Tallman, MD, Jordi Estev, Mei-Jie Zhang
Journal: Blood
Blood (2015) 126 (23): 928.
https://doi.org/10.1182/blood.V126.23.928.928
Published: 2015
Journal Articles

FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Abhinav Deol, MD, Salyka Sengsayadeth, MD, Madan Jagasia, MBBS, MS, Kwang W Ahn, PhD, Hailin Wang, MPH, Brenda M. Sandmaier, MD, Steven M. Devine, MD, Marcos de Lima, MD, Daniel J. Weisdorf, MD, Wael Saber, MD MS
Journal: Blood
Blood (2014) 124 (21): 322.
https://doi.org/10.1182/blood.V124.21.322.322
Published: 2014
Journal Articles

Survival Of AML Patients Relapsing After Allogeneic Stem Cell Transplantation: A Center For International Blood and Marrow Transplant Research Study

Nelli Bejanyan, MD, Daniel J. Weisdorf, MD, Hailin Wang, MS, Brent R. Logan, PhD, Steven M. Devine, MD, Marcos de Lima, MD, Donald W. Bunjes, MD, Mei-Jie Zhang, PhD
Journal: Blood
Blood (2013) 122 (21): 2072.
https://doi.org/10.1182/blood.V122.21.2072.2072
Published: 2013
Journal Articles

Autologous Hematopoietic Cell Transplantation (HCT) Is Superior To Allogeneic Transplantation For Acute Promyelocytic Leukemia In Second Complete Remission (CR2)

Jennifer L. Holter-Chakrabarty, MD, Morel Rubinger, MD, Andrew Grigg, MBBS, FRACP, FRCPA, Jeffrey Szer, MBBS, George Selby, MD, Jacob M Rowe, MD, Jennifer Le Rademacher, PhD, Hailin Wang, MS, Daniel J. Weisdorf, MD, Martin S Tallman, MD
Journal: Blood
Blood (2013) 122 (21): 418.
https://doi.org/10.1182/blood.V122.21.418.418
Published: 2013
Journal Articles

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: A Cibmtr Analysis

John Koreth, MBBS, DPhil, Kwang Woo Ahn, PhD, Joseph Pidala, MD, MS, James L. Gajewski, MD, Hailin Wang, MS, Marcelo A. Fernandez Viña, PhD, D(ABHI), Stephen Spellman, MBS, Stephanie J. Lee, MD, MPH
Journal: Blood
Blood (2013) 122 (21): 547.
https://doi.org/10.1182/blood.V122.21.547.547
Published: 2013